Literature DB >> 19176229

Reduced NADH coenzyme Q dehydrogenase activity in platelets of Parkinson's disease, but not Parkinson plus patients, from an Indian population.

Merina Varghese1, Mritunjay Pandey, Ananda Samanta, Prasanta Kumar Gangopadhyay, Kochupurackal P Mohanakumar.   

Abstract

The observation of decline in mitochondrial electron transport chain function, specifically at complex I, in patients with Parkinson's disease (PD) has been reported by several groups. This study investigates whether a defect of mitochondrial function is present in the platelets of PD patients from an Indian population. We found that the NADH dehydrogenase activity in the platelets of PD patients is lower than that in healthy age- and gender-matched controls, while the succinate dehydrogenase activity was similar in both groups. Furthermore, there was no change in either of the activities in patients with Parkinson plus syndrome or atypical parkinsonism. This is the first report indicating a decline in mitochondrial function in the platelets of PD patients from the Indian population, offering further support to the role of a mitochondrial defect in PD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19176229     DOI: 10.1016/j.jns.2008.12.021

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  12 in total

Review 1.  Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease.

Authors:  L Holper; D Ben-Shachar; J J Mann
Journal:  Neuropsychopharmacology       Date:  2018-05-16       Impact factor: 7.853

Review 2.  The role of mitochondria in neurodegenerative diseases.

Authors:  Massimiliano Filosto; Mauro Scarpelli; Maria Sofia Cotelli; Valentina Vielmi; Alice Todeschini; Valeria Gregorelli; Paola Tonin; Giuliano Tomelleri; Alessandro Padovani
Journal:  J Neurol       Date:  2011-05-22       Impact factor: 4.849

3.  Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson's Disease.

Authors:  Debashis Dutta; Nilufar Ali; Emili Banerjee; Raghavendra Singh; Amit Naskar; Ramesh Kumar Paidi; Kochupurackal P Mohanakumar
Journal:  Mol Neurobiol       Date:  2017-01-06       Impact factor: 5.590

4.  Large-scale mapping of mammalian transcriptomes identifies conserved genes associated with different cell states.

Authors:  Yang Yang; Yu-Cheng T Yang; Jiapei Yuan; Zhi John Lu; Jingyi Jessica Li
Journal:  Nucleic Acids Res       Date:  2017-02-28       Impact factor: 16.971

5.  Platelet mitochondrial activity and pesticide exposure in early Parkinson's disease.

Authors:  Jeff M Bronstein; Kimberly Paul; Laurice Yang; Richard H Haas; Clifford W Shults; Thuy Le; Beate Ritz
Journal:  Mov Disord       Date:  2015-03-11       Impact factor: 10.338

6.  Parkinson's disease: from molecular pathways in disease to therapeutic approaches.

Authors:  Bobby Thomas
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

7.  Stabilization of NADH-dehydrogenase in mitochondria by guanosine phosphates and adenosine phosphates.

Authors:  M S Frolova; N L Vekshin
Journal:  J Fluoresc       Date:  2014-04-11       Impact factor: 2.217

Review 8.  Mitochondrial medicine for neurodegenerative diseases.

Authors:  Heng Du; Shirley ShiDu Yan
Journal:  Int J Biochem Cell Biol       Date:  2010-01-11       Impact factor: 5.085

9.  Oxidative stress in skin fibroblasts cultures from patients with Parkinson's disease.

Authors:  Pilar del Hoyo; Alberto García-Redondo; Fernando de Bustos; José Antonio Molina; Youssef Sayed; Hortensia Alonso-Navarro; Luis Caballero; Joaquín Arenas; José A G Agúndez; Félix Javier Jiménez-Jiménez
Journal:  BMC Neurol       Date:  2010-10-19       Impact factor: 2.474

10.  Near-infrared 808 nm light boosts complex IV-dependent respiration and rescues a Parkinson-related pink1 model.

Authors:  Melissa Vos; Blaise Lovisa; Ann Geens; Vanessa A Morais; Georges Wagnières; Hubert van den Bergh; Alec Ginggen; Bart De Strooper; Yanik Tardy; Patrik Verstreken
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.